Clinical trial
Identification of Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
NCT01206426 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
- Lead sponsor
- University of Chicago
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- October 16, 2017
- Enrollment
- 79 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
urothelial cancer